投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
1.9 %
年文章数
963
作者需知
暂无数据
NCBI查询
期刊简介
稿件收录要求
稿件收录要求
Published by Elsevier Science.
ISSN: 1537-1891.
Vascular Pharmacology publishes papers, written in English, which contain results of all aspects of pharmacology of the vascular system. Papers are encouraged in all areas, including angiogenesis, growth factors, nitric oxide, cell signaling, vasoactive mediators, hypertension, atherosclerosis, metabolic diseases, blood element-vessel wall interactions, thrombosis, microcirculation, vascular developmental biology and remodeling, vascular inflammation and immunity. Papers are encouraged on pharmacological research utilizing approaches ranging from molecular biology to integrative physiology.
Vascular Pharmacology publishes papers, written in English, which contain results of all aspects of pharmacology of the vascular system. Papers are encouraged in all areas, including angiogenesis, growth factors, nitric oxide, cell signaling, vasoactive mediators, hypertension, atherosclerosis, metabolic diseases, blood element-vessel wall interactions, thrombosis, microcirculation, vascular developmental biology and remodeling, vascular inflammation and immunity. Papers are encouraged on pharmacological research utilizing approaches ranging from molecular biology to integrative physiology.
